SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Bioterrorism -- Ignore unavailable to you. Want to Upgrade?


To: Paul Kern who wrote (131)10/8/2001 10:30:49 AM
From: Frederick Langford  Read Replies (1) | Respond to of 891
 
Scroll down to bold print:

U.S.-led Attacks Could Fuel More Defense Stock Gains

October 08, 2001 04:30:15 (ET)

NEW YORK/SINGAPORE, Oct 8 (Reuters) - The United States and Britain opened their arsenals on Sunday, using a bevy of U.S.-made weapons in the attack on Afghanistan, and leading Wall Street analysts expect a renewed rally in defense stocks.

Ahead of Wall Street's opening on Monday, Singapore-based ST Engineering ((STEG.SI)) pointed to positive sentiment toward the sector, by bucking a weak market to rise nearly four percent on Monday. At 0729 GMT, it had surrendered some ground but was still up six cents at S$2.08.

ST is Asia's largest listed defence contractor and it operates two hangars in the United States that service aircraft.

"The market is really quite cautious and overall market volume is thin. But ST Engineering is seen as benefiting as it is a defence stock," said a dealer with a Singapore brokerage.

Investors anticipated a U.S. military response to the September 11 attack on the United States, and boosted shares of defense contractors accordingly.

While the stocks rally was weighted toward makers of military electronics, the start of actions against Afghanistan could spark wholesale buying, they said.

"Defense stocks are easy -- they'll go up," said Phil Orlando, chief investment officer of Value Line's Asset Management division, referring to U.S. stocks.

"Most of these stocks shot up significantly right with the attacks a couple weeks ago, which is exactly what you'd expect," he said on Sunday. "That wouldn't discount the fact that the stocks would probably rally further given the initiation of our military activity."

LAND, SEA-BASED WEAPONS

Both land and sea-based weapons, along with aircraft and cruise missiles, were employed in the strikes, a senior military official said. Among those, 15 U.S. bombers, 25 strike aircraft and 50 cruise missiles were used, the official said.

Northorp Grumman Corp (NOC,Trade), maker of the B-2 stealth bomber and a leader in electronics and surveillance technology, saw its stock jump more than 30 percent since Sept. 11.

Other bombers said to be used in the attack -- the B-1 and the B-52 -- are made by Boeing Co (BA,Trade). The B-52 Stratofortress is a long-range heavy bomber that can carry nuclear or precision-guided weapons. The B-1 Lancer is a heavy bomber capable of flying at speeds of Mach 1.2 at sea level.

Boeing's stock, however, has been pressured by its exposure to commercial aerospace amid a crisis in the airline industry. Shares have fallen more than 16 percent since September 11.

MISSILES BUILT BY MANY

Cruise missiles are built by a number of companies. The term covers several vehicles and their capabilities but most often refers to missiles such as the U.S. Advanced Cruise Missile, which can fly to ranges of up to 3,000 km.

The Tomahawk cruise missile, designed to fly at low altitudes at high subsonic speeds, is built by Raytheon Co (RTN,Trade). It is used by both the U.S. and British militaries and considered difficult to detect due to its small radar cross-section and low flight.

Shares of Lexington, Massachusetts-based Raytheon, which also makes the Patriot air and missile defense system, have gained nearly 41 percent since September 11.

Israeli company Rafael Armament Development Authority designed the AGM-142 precision guided, medium range, air-to-surface missile -- fielded on the B-52 in 1992.

Lockheed Martin Corp (LMT,Trade), the nation's No. 1 defense contractor, produces Fleet Ballistic Missiles.

Its Trident II D5, a submarine-launched ballistic missile with a range of more than 4,000 nautical miles, may have been used in the attack. British Prime Minister Tony Blair said submarines had launched missiles at Afghanistan on Sunday.

Lockheed also builds the F-16 fighter jet. McDonnell Douglas, now part of Boeing, built the F-15 tactical fighter.

Shares of Bethesda, Maryland-based Lockheed have climbed 25 percent since September 11.

CONTRACT HOPES PREMATURE

Despite Monday's gains for Singapore's ST Engineering, however, the stock is down about 11 percent since September 11.

Expectations ST Engineering could secure new military contracts as a result of the U.S.-led war on terrorism were also premature, analysts in Singapore said.

The outlook for ST, which has been diversifying into civilian aircraft maintenance, remains cloudly with the severe downturn in the U.S. aviation industry, and analysts say they hope to get a better handle on the outlook at the company's third quarter results briefing later on Tuesday.

BEYOND HARDWARE

After September 11, many defense industry and Wall Street analysts predicted higher spending on warfare technologies. Some noted spending could be focused on intelligence along with precision weapons and chemical defenses.

Among those analysts, First Union's Sam Pearlstein named Alliant Techsystems Inc (ATK,Trade) and L-3 Communications Holdings Inc (LLL,Trade) as leaders in important warfare areas, along with Northrop, Lockheed, Raytheon and General Dynamics Corp (GD,Trade).

Alliant Techsystems and L-3 both rallied over the last two weeks, with share prices jumping more than 35 percent.

Bruker Daltonics Inc (BDAL,Trade), maker of equipment to detect agents used in biological warfare, saw its stock rise eight percent after September 11, and analysts said the company could benefit from heightened concerns about biological attacks.

Deutsche Banc Alex. Brown analyst Christopher Mecray has noted many U.S.-led military actions could be more manpower-intensive than equipment-intensive, given actions needed to gather intelligence and conduct surveillance. But in what he called the "medium-term," the quickened tempo of military activity could ultimately demand spending on equipment.

© Copyright 2001 Reuters. Click Here for Limitations and Restrictions on Use.

Fred



To: Paul Kern who wrote (131)10/8/2001 4:50:42 PM
From: nigel bates  Read Replies (1) | Respond to of 891
 
Reuters report on the second anthrax case. If accurate, the details are a little disturbing, but no reason for panic -

WASHINGTON (Reuters) - News that a second Florida man has tested positive for exposure to anthrax is worrying, but it will be easy to prevent an outbreak of disease with drugs, medical experts have said.
The Federal Bureau of Investigation is treating the case -- in which 63-year-old Robert Stevens died and another person became infected -- as a potential criminal investigation, Attorney General John Ashcroft said.
Medical experts said that is understandable, because there is no easy natural way for anthrax spores to have gotten into the building where Stevens worked.
But anthrax disease is very easy to treat with antibiotics, if people get the drugs before they start to show symptoms.
"It's very hard to find a benign explanation, so it is upsetting," Theresa Koehler, an assistant professor of microbiology at the University of Texas Health Sciences Center, said in a telephone interview.
"They found spores in the building. That's very suspect," said Koehler, an expert on anthrax. "It is unheard of that you would find spores in a building like this."
A man who worked with Stevens tested positive for anthrax but was ill with unrelated symptoms, Florida health officials said. They did not release the man's name, but said he was in his 70s.
Bioterrorism specialists have been saying for years that the United States is very susceptible to a biological or chemical weapons attack, and they have named anthrax as a prime agent because it is easily spread and deadly when it takes the form of airborne spores.
Fears of a deliberate release of an agent such as anthrax spores have been heightened since the Sept. 11 attacks on the World Trade Center in New York, the Pentagon, and the hijacking of an airliner that crashed in Pennsylvania.
State health officials said they found anthrax on the computer keyboard of Stevens, who worked as a photographer at The Sun, a supermarket tabloid in Boca Raton, Florida.
He had pulmonary anthrax, which had not been previously seen in the United States since 1976. Stevens died last Friday after being admitted to a hospital earlier in the week.
The building where the two men worked was closed on Monday and was to be examined by health and law enforcement personnel. Workers and visitors to the building in recent weeks were asked to contact health officials.
"I could understand people panicking," Koehler said. But she said anyone who worked in or near the building was being tested. "Everyone is going to get swabbed nasally to see if they are carrying spores," she said.
Tests had already shown that this particular strain of anthrax was easy to treat, Donald A. Henderson, head of the Center for Civilian Biodefense Studies at Johns Hopkins University in Baltimore, said in a telephone interview.
"It certainly is not an engineered strain, not a strain like the Russians produced and wrote about -- they said they had produced an antibiotic-resistant strain," Henderson said.
Henderson and Koehler said anyone who had anthrax spores in the nose would be treated with antibiotics.
"People will go on antibiotics -- ciprofloxacin. That is the good news," Koehler said.
"It is not contagious. It's a frightening situation but if you look at it -- if this was a release, it sure didn't work very well."
And, Koehler added, it is conceivable that the two men were exposed months ago.
"We don't know when he (Stevens) was exposed," she said. "When you experience symptoms is related to dose and time of exposure. He could have gotten a very low dose a long time ago. If you get a huge dose you can get symptoms in a couple of days."